Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the efficacy and safety of ARC-4558 for managing pain in patients with Painful Diabetic Neuropathy. Results have been posted followi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARC-4558

Snippet

Sponsor: Arcion Therapeutics Inc | Conditions: Painful Diabetic Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2016-11-08